Clinical Trials Logo

Clinical Trial Summary

It is important for clinicians to maintain and support for exercise capacity and quality of life of lung cancer patients after radiation therapy, because radiation therapy also affect the lung function and general conditions of patients. The effect and safety of pulmonary rehabilitation is well-proven in various diseases. Because there is no standard treatment, the investigators will perform this study to clearly prove the effect of pulmonary rehabilitation in lung cancer patients receiving radiation therapy.


Clinical Trial Description

Roles of the radiation therapy in lung cancer are as followings; 1) to treat the lung caner stage 1 ~2 patients, who are inadequate for operation due to declined lung function, 2) to treat the locally advanced and inoperable stage 3 patients with concurrent chemotherapy, and 3) to palliatively treat the stage 4 patient. However, it is also possible that radiation therapy worsens the general weakness and lung function, although the degree of deterioration was generally less than lung resection. Therefore, it is crucial for clinicians to maintain and support for exercise capacity and quality of life of lung cancer patients after radiation therapy. The effect and safety of pulmonary rehabilitation is well-proven in various diseases. Investigators presented a retrospective study about the effect of pulmonary rehabilitation in patients receiving radiation therapy, which showed less decreased lung function, less radiation related pneumonitis, and decreased mortality. Investigators will perform this study to clearly prove the effect of pulmonary rehabilitation in lung cancer patients receiving radiation therapy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05414188
Study type Interventional
Source Asan Medical Center
Contact Sei Won Lee, MD, PhD
Phone +82-2-3010-3990
Email iseiwon@gmail.com
Status Not yet recruiting
Phase N/A
Start date June 14, 2022
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05890872 - Aliyaâ„¢ Pulsed Electric Fields (PEF) for Advanced Cancer N/A
Recruiting NCT05974475 - MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
Recruiting NCT06079970 - Confocal Laser Endomicroscopy VERification N/A
Recruiting NCT04973293 - Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer N/A
Recruiting NCT04778826 - Immune Response Following Lobectomy Along With or Without Bilateral Transcervical Mediastinal Lymphadenectomy N/A
Suspended NCT04036721 - Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis Phase 4
Completed NCT03352245 - Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer N/A
Completed NCT03834116 - Resistance Inspiratory Muscle Training for Patients With Thoracic Malignancies N/A
Completed NCT03824977 - Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery
Terminated NCT02985203 - Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer Phase 2
Recruiting NCT06440616 - Benefit of Spectral Information in Patients Suspected for Lung Cancer N/A
Active, not recruiting NCT05241873 - (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations Phase 1/Phase 2
Completed NCT05404022 - Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years N/A
Recruiting NCT03525782 - Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC Phase 1/Phase 2
Completed NCT04059887 - Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY] Phase 4
Terminated NCT05013554 - Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors Phase 1